MBL2 and hypopituitarism: Regarding the first point (i.e. appropriate vs. inappropriate hormone replacement therapies) it has been statistically confirmed (Figure 4) that patients with compensated hypopituitarism have higher mean and median MBL levels when compared to patients with non-compensated hypopituitarism.